Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Neurosci Lett ; 826: 137730, 2024 Mar 15.
Article En | MEDLINE | ID: mdl-38485080

PURPOSE: Considering that the combination of dasatinib and quercetin (D + Q) demonstrated a neuroprotective action, as well as that females experience a decline in hormonal levels during aging and this is linked to increased susceptibility to Alzheimer's disease, in this study we evaluated the effect of D + Q on inflammatory and oxidative stress markers and on acetylcholinesterase and Na+, K+-ATPase activities in brain of female mice. METHODS: Female C57BL/6 mice were divided in Control and D (5 mg/kg) + Q (50 mg/kg) treated. Treatment was administered via gavage for three consecutive days every two weeks starting at 30 days of age. The animals were euthanized at 6 months of age and at 14 months of age. RESULTS: Results indicate an increase in reactive species (RS), thiol content and lipid peroxidation followed by a reduction in nitrite levels and superoxide dismutase, catalase and glutathione S-transferase activity in the brain of control animals with age. D+Q protected against age-associated increase in RS and catalase activity reduction. Acetylcholinesterase activity was increased, while Na+, K+-ATPase activity was reduced at 14 months of age and D+Q prevented this reduction. CONCLUSION: These data demonstrate that D+Q can protect against age-associated neurochemical alterations in the female brain.


Acetylcholinesterase , Senotherapeutics , Rats , Female , Mice , Animals , Catalase/metabolism , Acetylcholinesterase/metabolism , Rats, Wistar , Mice, Inbred C57BL , Antioxidants/pharmacology , Oxidative Stress , Quercetin/pharmacology , Brain/metabolism , Superoxide Dismutase/metabolism , Adenosine Triphosphatases
...